先进治疗药物开发 - - 从指南到市场上的药物
Catarina Frederico1, André Conceição2, Clévio Nóbrega2
1Faculty of Science and Technology, University of Algarve, 8005-139 Faro, Portugal.
Biotechnology advances
|May 24, 2025
概括
先进治疗药物 (ATMP) 为未满足的医疗需求提供了创新的治疗方法. 本综述审查了欧洲基因,细胞和组织治疗的监管环境和发展挑战.
科学领域:
- 生物医学科学 生物医学科学
- 监管科学 监管科学
- 药理学 药理学是指药理学的学科.
背景情况:
- 先进疗法药物 (ATMP) 代表了一种新型药物类别,包括基因疗法,体细胞疗法和组织工程产品.
- 这些疗法解决了各种病理的重大未满足的医疗需求,为疾病治疗和恢复功能提供了潜力.
- 尽管有希望,但ATMP在科学复杂性,制造,监管批准和市场准入方面面临重大障碍.
研究的目的:
- 审查目前欧洲ATMP非临床和临床开发的监管框架.
- 讨论适用于不同类型的ATMP的具体法规.
- 识别和分析在ATMP开发过程中遇到的挑战,从早期研究到市场可用性.
主要方法:
- 审查关于ATMP开发的官方欧洲指南.
- 对概念验证,生物分布和毒理学研究的监管要求进行分析.
- 讨论病毒载体集成,瘤性和生殖系传播评估方面的挑战.
- 检查市场准入的监管途径.
主要成果:
- 该审查概述了重要的非临床研究,包括概念验证,生物分布和毒理学,这对ATMP开发至关重要.
- 它详细介绍了病毒载体集成的监管考虑因素,瘤性潜力和生殖系传播的可能性.
- 该工作还强调了欧盟市场中患者可用的现有ATMP.
结论:
- 导航监管环境对于ATMPs的成功开发和可用性至关重要.
- 解决科学和生产复杂性,以及监管障碍,对于将这些创新疗法带给患者至关重要.
- 了解不同ATMP类型的特定要求,有助于它们在临床开发和市场授权过程中取得进展.
相关概念视频
Clinical Trials: Overview
3.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.4K
Preclinical Development: Overview
4.9K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.9K
Drug Administration and Therapy Phases: Overview
788
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
788
Microorganisms in Medicine and Therapeutics
384
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
384
Clinical Trials
9.3K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
9.3K
Drug Regulation
1.9K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.9K


